Performance of LC–MS/MS and immunoassay based 24-h urine free cortisol in the diagnosis of Cushing's syndrome

24-h urine free cortisol (UFC) is an indicator of integrated cortisol secretion and established screening tool for Cushing's syndrome (CS). Doubts have been raised regarding specificity of immunoassays, and mass spectrometric techniques have been proposed as an alternative. In the present study we compared diagnostic accuracy of UFC measured with LC-MS/MS vs. immunoassay in patient with CS and patients where CS has been excluded. We examined 24-h urine samples from patients with surgically confirmed CS (n = 77; Cushing's disease (n = 44), ectopic CS (n = 5), adrenal CS (n = 28)) and patients in whom Cushing's syndrome was excluded (n = 97) by long-term follow up. UFC was first measured by automated chemiluminescence immunoassays (ADVIA Centaur, Siemens; LIAISON, DiaSorin). Aliquots of all samples were also analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Statistics: Passing-Bablok Regression, Receiver operating characteristic (ROC) analysis with Youden's index calculation. UFC of CS patients were higher with both immunoassays compared to LC-MS/MS (913 +/- 235 vs. 303 +/- 155 μg/24 h (ADVIA) and 898 +/-216 vs. 399 +/- 196 μg/24 h (LIAISON)). Similarly, UFC were higher with immunoassays than with LC-MS/MS in the control group (223 +/- 10 vs. 23 +/- 2 μg/24 h (ADVIA) and 105 +/- 6 vs. 27 +/- 4 ug/24 h for (LIAISON)). Passing-Bablok regression showed good correlation between LC-MS/MS and ADVIA as well as between LCMS/MS and LIAISON (r = 0.96 and r = 0.99, p < 000.1) but less correlation in controls (r = 0.83 and r = 0.74, respectively, p < 000.1). ROC calculation revealed the highest ROC AUC (0.89) for the LIAISON immunoassay, followed by LC-MS/MS (0.82) and the ADVIA (0.80). In direct comparison, AUCs from LC-MS/MS and immunoassays in the same patient were not statistically different (p < 0,001). Best cut-off concentration to identify patients with CS was 234 μg/24 h (LIAISON), 51 μg/24 h for LC-MS/MS and 330 μg/24 h (ADVIA Centaur). In summary, UFC values were measured substantially higher by both immunoassays compared to LC-MS/MS. This is most likely due to cross-reactivity from interfering glucocorticoid metabolites. Nevertheless, all three methods correlated well. ROC analysis revealed the highest AUC for one of the immunoassays, although differences between the three methods were not significant. Direct comparison with LC-MS/MS indicates that high diagnostic accuracy can be obtained with suitable immunoassays.

[1]  G. Casals,et al.  Accuracy of immunoassay and mass spectrometry urinary free cortisol in the diagnosis of Cushing’s syndrome , 2016, Pituitary.

[2]  W. Drake,et al.  Investigation for Paediatric Cushing's Syndrome Using Twenty-Four-Hour Urinary Free Cortisol Determination , 2016, Hormone Research in Paediatrics.

[3]  F. Iavarone,et al.  A simple liquid chromatography-tandem mass spectrometry method for urinary free cortisol analysis: suitable for routine purpose , 2010, Clinical chemistry and laboratory medicine.

[4]  F. Ceccato,et al.  Cushing’s Syndrome: Screening and Diagnosis , 2016, High Blood Pressure & Cardiovascular Prevention.

[5]  H. Raff,et al.  Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia. , 2014, Comprehensive Physiology.

[6]  S. Gillingwater,et al.  Measurement of urinary free cortisol by tandem mass spectrometry and comparison with results obtained by gas chromatography-mass spectrometry and two commercial immunoassays , 2008, Annals of clinical biochemistry.

[7]  R. Auchus Steroid assays and endocrinology: best practices for basic scientists. , 2014, Endocrinology.

[8]  N. Lawson,et al.  Measurement of Urinary Free Cortisol Using the ACS:180 Serum Cortisol Chemiluminescent Immunoassay , 2000, Annals of clinical biochemistry.

[9]  B. Keevil,et al.  Novel liquid chromatography tandem mass spectrometry (LC-MS/MS) methods for measuring steroids. , 2013, Best practice & research. Clinical endocrinology & metabolism.

[10]  Esa Hämäläinen,et al.  Determination of cortisol in serum, saliva and urine. , 2013, Best practice & research. Clinical endocrinology & metabolism.

[11]  A. McCormack,et al.  How useful is urinary-free cortisol in the clinic? , 2017, Biomarkers in medicine.

[12]  H. Raff,et al.  Urine free cortisol in the diagnosis of Cushing's syndrome: is it worth doing and, if so, how? , 2015, The Journal of clinical endocrinology and metabolism.

[13]  A. Frigo,et al.  Screening Tests for Cushing's Syndrome: Urinary Free Cortisol Role Measured by LC-MS/MS. , 2015, The Journal of clinical endocrinology and metabolism.

[14]  J. Corcuff,et al.  LC-MSMS assays of urinary cortisol, a comparison between four in-house assays , 2018, Clinical chemistry and laboratory medicine.

[15]  D. Rees,et al.  Measuring cortisol in serum, urine and saliva – are our assays good enough? , 2017, Annals of clinical biochemistry.

[16]  L. Crapo,et al.  The Cushing syndrome: an update on diagnostic tests. , 1990, Annals of internal medicine.

[17]  A. Tichy,et al.  Configuration of antibodies for assay of urinary cortisol in dogs influences analytic specificity. , 2013, Domestic animal endocrinology.

[18]  V. Montori,et al.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[19]  W. Selman,et al.  Pitfalls in the diagnosis and management of Cushing's syndrome. , 2015, Neurosurgical focus.

[20]  T. Remer,et al.  Determination of free cortisol and free cortisone in human urine by on-line turbulent flow chromatography coupled to fused-core chromatography–tandem mass spectrometry (TFC–HPLC–MS/MS) , 2013, Analytical and Bioanalytical Chemistry.

[21]  G. Schuler,et al.  The art of measuring steroids Principles and practice of current hormonal steroid analysis , 2017, The Journal of Steroid Biochemistry and Molecular Biology.